Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Raphael

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Current Oncology (Toronto, Ont.)|July 25, 2025
Prioritizing the Timely Detection and Diagnosis of Early-Age Onset Cancer to Enable Optimal Disease Management and OutcomesMichael J Raphael, Petra Wildgoose, Darren Brenner, et al.
Current Oncology (Toronto, Ont.)|November 24, 2023
Breaking Down Barriers to Detection and Care in Early-Age-Onset Colorectal Cancer in CanadaMichael J Raphael, Petra Wildgoose, Filomena Servidio-Italiano, et al.
Seminars in Oncology|January 28, 2019
Medical oncology job satisfaction: Results of a global surveyMichael J Raphael, Adam Fundytus, Wilma M Hopman, et al.
JAMA Network Open|November 15, 2021
The Association of Drug-Funding Reimbursement With Survival Outcomes and Use of New Systemic Therapies Among Patients With Advanced Pancreatic CancerMichael J Raphael, William Raskin, Steven Habbous, et al.
Current Oncology (Toronto, Ont.)|July 26, 2024
Addressing the Rising Trend in Early-Age-Onset Cancers in CanadaPetra Wildgoose, Filomena Servidio-Italiano, Michael J Raphael, et al.
Journal of the National Cancer Institute|August 2, 2023
Mortality among patients with diffuse large B-cell lymphoma and mental disorders: a population-based studyInna Y Gong, Matthew C Cheung, Kelvin K W Chan, et al.
JNCI Cancer Spectrum|June 27, 2022
Real-World Cost-Effectiveness of First-Line Gemcitabine Plus Nab-Paclitaxel vs FOLFIRINOX in Patients With Advanced Pancreatic CancerVanessa Arciero, Jin Luo, Ambica Parmar, et al.
British Journal of Cancer|September 4, 2025
Recommendations for studying the association of the cancer diagnosis to treatment interval with overall survival: a modified Delphi processMatthew Jalink, Will D King, Benjamin O Anderson, et al.
JAMA Network Open|August 2, 2022
Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, CanadaSteven Habbous, Xiaochen Tai, Jaclyn M Beca, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Current Oncology (Toronto, Ont.)|July 25, 2025
Prioritizing the Timely Detection and Diagnosis of Early-Age Onset Cancer to Enable Optimal Disease Management and OutcomesMichael J Raphael, Petra Wildgoose, Darren Brenner, et al.
Current Oncology (Toronto, Ont.)|November 24, 2023
Breaking Down Barriers to Detection and Care in Early-Age-Onset Colorectal Cancer in CanadaMichael J Raphael, Petra Wildgoose, Filomena Servidio-Italiano, et al.
Seminars in Oncology|January 28, 2019
Medical oncology job satisfaction: Results of a global surveyMichael J Raphael, Adam Fundytus, Wilma M Hopman, et al.
JAMA Network Open|November 15, 2021
The Association of Drug-Funding Reimbursement With Survival Outcomes and Use of New Systemic Therapies Among Patients With Advanced Pancreatic CancerMichael J Raphael, William Raskin, Steven Habbous, et al.
Current Oncology (Toronto, Ont.)|July 26, 2024
Addressing the Rising Trend in Early-Age-Onset Cancers in CanadaPetra Wildgoose, Filomena Servidio-Italiano, Michael J Raphael, et al.
Journal of the National Cancer Institute|August 2, 2023
Mortality among patients with diffuse large B-cell lymphoma and mental disorders: a population-based studyInna Y Gong, Matthew C Cheung, Kelvin K W Chan, et al.
JNCI Cancer Spectrum|June 27, 2022
Real-World Cost-Effectiveness of First-Line Gemcitabine Plus Nab-Paclitaxel vs FOLFIRINOX in Patients With Advanced Pancreatic CancerVanessa Arciero, Jin Luo, Ambica Parmar, et al.
British Journal of Cancer|September 4, 2025
Recommendations for studying the association of the cancer diagnosis to treatment interval with overall survival: a modified Delphi processMatthew Jalink, Will D King, Benjamin O Anderson, et al.
JAMA Network Open|August 2, 2022
Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, CanadaSteven Habbous, Xiaochen Tai, Jaclyn M Beca, et al.
Pageof 3